BIG
RVMD icon

Brooklyn Investment Group’s Revolution Medicines RVMD Stock Holding History

Brooklyn Investment Group’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$875K Buy
8,994
+3,830
+74% +$387K 0.03% 645
2025
Q4 		$416K Buy
+5,164
New +$339K 0.02% 797
2025
Q3 		– Sell
-495
Closed -$18.2K – 2261
2025
Q2 		$18.2K Buy
495
+481
+3,436% +$18.5K ﹤0.01% 1870
2025
Q1 		$496 Buy
14
+11
+367% +$447 ﹤0.01% 2492
2024
Q4 		$132 Buy
+3
New +$151 ﹤0.01% 1806

Other funds holding RVMD

FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Brooklyn Investment Group's RVMD Position: Q1 2026 in Review

Brooklyn Investment Group increased its Revolution Medicines (RVMD) stake by 74% in Q1 2026, buying an estimated $387K and bringing the position to 8,994 shares worth $875K. The position accounts for 0.03% of the portfolio, ranked #645.

Brooklyn Investment Group first reported a position in RVMD in Q4 2024 and has held it in 5 quarters since. 514 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

  • Brooklyn Investment Group held 8,994 shares of Revolution Medicines worth $875K as of Q1 2026.
  • Brooklyn Investment Group bought 3,830 Revolution Medicines shares in Q1 2026, an estimated $387K.
  • Revolution Medicines made up 0.03% of Brooklyn Investment Group's portfolio in Q1 2026, its #645 holding.
  • Brooklyn Investment Group first reported a position in Revolution Medicines in Q4 2024 and has held it in 5 quarters since.
  • 514 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on Brooklyn Investment Group's 13F filing for Q1 2026, filed 29 Apr 2026.